Ayala Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ayala Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2023 was 6.02M shares, a 108% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 6.02M shares, a 108% increase from 2022.
  • Ayala Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.9M shares, a 79.4% increase from 2021.
  • Ayala Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.61M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 6.02M +3.12M +108% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 4.78M +1.88M +64.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 4.78M +1.91M +66.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 4.41M +1.54M +53.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-23
Q4 2022 2.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 2.9M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 2.87M +1.05M +57.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 2.87M +1.33M +86.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q2 2021 1.82M May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 1.54M -59M -97.5% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-08
Q1 2020 60.6M +54.7M +927% Feb 1, 2020 Apr 30, 2020 10-Q 2020-06-11
Q4 2019 51.7M +47.1M +1015% Nov 1, 2019 Jan 31, 2020 10-Q 2020-03-13
Q1 2019 5.9M +2.58M +77.5% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-11
Q4 2018 4.64M -36.8M -88.8% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q1 2018 3.32M Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q4 2017 41.4M Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-12
Q4 2013 13.8M +10.3M +288% Nov 1, 2013 Jan 31, 2014 10-Q 2014-03-17
Q3 2013 5.01M +2.45M +95.4% Aug 1, 2013 Oct 31, 2013 10-K 2014-01-29
Q2 2013 4.78M +2M +72.1% May 1, 2013 Jul 31, 2013 10-Q 2013-09-16
Q1 2013 529M +243M +85.3% Feb 1, 2013 Apr 30, 2013 10-Q 2013-06-14
Q4 2012 3.57M -259M -98.6% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 2.56M -220M -98.8% Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 2.77M -226M -98.8% May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 285M +72M +33.7% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 263M +56M +27.1% Nov 1, 2011 Jan 31, 2012 10-Q/A 2013-03-25
Q3 2011 223M Aug 1, 2011 Oct 31, 2011 10-K/A 2013-02-14
Q2 2011 228M +62.3M +37.5% May 1, 2011 Jul 31, 2011 10-Q/A 2012-10-04
Q1 2011 213M Feb 1, 2011 Apr 30, 2011 10-Q/A 2012-10-18
Q4 2010 207M Nov 1, 2010 Jan 31, 2011 10-Q/A 2012-10-18
Q2 2010 166M May 1, 2010 Jul 31, 2010 10-Q 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.